In both mice and humans, mutations in the genes encoding the endothelin B r
eceptor and its ligand endothelin 3 lead to deficiencies in neural crest-de
rived melanocytes and enteric neurons. The discrete steps at which endothel
ins exert their functions in melanocyte development were examined in mouse
neural crest cell cultures. Such cultures, kept in the presence of fetal ca
lf serum, gave rise to cells expressing the early melanoblast marker Dct ev
en in the absence of the phorbol eater tetradecanoyl phorbol acetate (TPA)
or endothelins. However, these early Dct(+) cells did not proliferate and p
igmented cells never formed unless TPA or endothelins were added. In fact,
endothelin 2 was as potent as TPA in promoting the generation of both Dctmelanoblasts and pigmented cells, and endothelin 1 or endothelin 3 stimulat
ed the generation of melanoblasts and of pigmented cells to an even greater
extent. The inhibition of this stimulation by the selective endothelin B r
eceptor antagonist BQ-788 (N-cis-2,6-dimethylpiperidinocarbonyl-L-alpha-met
hylleucyl-D-1-methoxycarbonyltryptophanyl-D-norleucine) suggested that the
three endothelins all signal through the endothelin B receptor. This recept
or was indeed expressed in Dct(+) melanoblasts, in addition to cells lackin
g Dct expression. The results demonstrate that endothelins are potent stimu
lators of melanoblast proliferation and differentiation.